Cargando…

OC-02 Khorana risk score at diagnosis of SARS-CoV-2 infection as a predicting tool for venous thromboembolic disease development, and overall mortality, in cancer patients

Detalles Bibliográficos
Autores principales:	López Jiménez, C., Blanco Abad, C., Catoya Villa, J.L., Gutiérrez Ortiz de la Tabla, A., Juliao Caamaño, D.S., Ortega Morán, L., Martín Jiménez, M., Muñoz Martín, A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Oral Communications
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057539/ http://dx.doi.org/10.1016/S0049-3848(21)00144-4

Ejemplares similares

PO-21 Incidence of venous thromboembolism events in outpatients with cancer and COVID-19.
por: Gutiérrez Ortiz de la Tabla, A., et al.
Publicado: (2021)

PO-56 Relationship between clinical presentation of SARS-CoV-2 infection and risk of thromboembolic events and prognosis in cancer patients
por: Catoya Villa, J.L., et al.
Publicado: (2021)

PO-58 Venous and arterial tromboembolic events among hospitalized cancer patients with SARS-COV2 infection
por: Blanco Abad, C., et al.
Publicado: (2021)

Using the Khorana risk score to predict venous thromboembolism and overall survival in a cohort of Hispanic patients with solid malignancies
por: Ramos-Esquivel, Allan, et al.
Publicado: (2022)

Evaluation of the Khorana score for prediction of venous thromboembolism in patients with multiple myeloma
por: Sanfilippo, Kristen M., et al.
Publicado: (2022)

Validation of the Khorana Venous Thromboembolism Risk Score in Japanese Cancer Patients
por: Akasaka-Kihara, Fumie, et al.
Publicado: (2021)

Use of the Khorana score to predict venous thromboembolism in patients undergoing chemotherapy for uterine cancer
por: Piver, Rachael N., et al.
Publicado: (2023)

Evaluation of the Khorana, PROTECHT, and 5‐SNP scores for prediction of venous thromboembolism in patients with cancer
por: Guman, Noori A. M., et al.
Publicado: (2021)

The Khorana score for prediction of venous thromboembolism in cancer patients: a systematic review and meta-analysis
por: Mulder, Frits I., et al.
Publicado: (2019)

Validation of the Khorana score for predicting venous thromboembolism in 40 218 patients with cancer initiating chemotherapy
por: Overvad, Thure Filskov, et al.
Publicado: (2022)

Prediction of venous thromboembolism in newly diagnosed patients treated for lymphoid malignancies: validation of the Khorana Risk Score
por: Rupa-Matysek, Joanna, et al.
Publicado: (2017)

Clinical Benefits of Oral Anticoagulant Use in Cancer Patients at Increased Risk for Venous Thromboembolism per Khorana Index
por: Choi, Yeo Jin, et al.
Publicado: (2021)

Retrospective Cohort Study of Venous Thromboembolism Rates in Ambulatory Cancer Patients: Association With Khorana Score and Other Risk Factors
por: Austin, Keziah, et al.
Publicado: (2019)

Validation of the Khorana Score to Assess Venous Thromboembolism and Its Association with Mortality in Cancer Patients: A Retrospective Community-based Observational Experience
por: Ahmed, Gulrayz, et al.
Publicado: (2020)

Har Gobind Khorana (1922–2011): Pioneering Spirit
por: Sakmar, Thomas P.
Publicado: (2012)

IT inventory and resource management with OCS inventory NG 1.02
por: Antal, Barzan
Publicado: (2010)

OC-01 Venous thromboembolic events during the first and second waves of Covid-19 in breast cancer patients treated in an outpatient day hospital
por: Illarramendi, J., et al.
Publicado: (2021)

Identification of risk factors for venous thromboembolism and validation of the Khorana score in patients with advanced lung cancer: based on the multicenter, prospective Rising-VTE/NEJ037 study data
por: Tsubata, Yukari, et al.
Publicado: (2022)

Khorana score and thromboembolic risk in stage II–III colorectal cancer patients: a post hoc analysis from the adjuvant TOSCA trial
por: Barni, Sandro, et al.
Publicado: (2020)

OC.02.9 IMPACT OF COVID-19 OUTBREAK ON GASTRO-INTESTINAL CANCER BURDEN
por: Milluzzo, S.M., et al.
Publicado: (2021)

Corrigendum to “Khorana score and thromboembolic risk in stage II–III colorectal cancer patients: a post hoc analysis from the adjuvant TOSCA trial”
Publicado: (2020)

Overall and abdominal obesity in relation to venous thromboembolism
por: Yuan, Shuai, et al.
Publicado: (2020)

Evaluation of the Khorana Predictive Thrombotic Risk and Thromboprophylaxis Score in Cancer Patients in a Third Level Hospital
por: Bermejo, Lara Almudena Fernández, et al.
Publicado: (2022)

Khorana Score: Νew Predictor of Early Mortality in Patients With Lung Adenocarcinoma
por: Vathiotis, Ioannis, et al.
Publicado: (2018)

Learning from Gobind Khorana: “The difficult we do today, the impossible tomorrow”
por: Subramaniam, Sriram
Publicado: (2022)

Expression systems for bovine rhodopsin: a review of the progress made in the Khorana laboratory
por: Reeves, Philip J.
Publicado: (2023)

Validation of the Khorana score in acute myeloid leukemia patients: a single-institution experience
por: Mirza, Abu-Sayeef, et al.
Publicado: (2019)

Cancer associated thrombosis and mortality in patients with cancer stratified by khorana score risk levels
por: Khorana, Alok A., et al.
Publicado: (2020)

Clinical guide SEOM on venous thromboembolism in cancer patients
por: Muñoz Martín, A. J., et al.
Publicado: (2014)

The Khorana score and venous and arterial thrombosis in patients with cancer treated with immune checkpoint inhibitors: A Danish cohort study
por: Overvad, Thure F., et al.
Publicado: (2022)

OC.02.2 REDUCED EXPRESSION OF SARS-COV-2 INFECTION-RELATED GENES IN INFLAMMATORY BOWEL DISEASE PATIENTS
por: Pisani, L.F., et al.
Publicado: (2022)

Risk of myocardial infarction and overall mortality in survivors of venous thromboembolism
por: Huerta, Consuelo, et al.
Publicado: (2008)

1582P Thromboembolic disease in COVID-19 cancer patients: Impact on overall survival and prognostic factors
por: Pertejo, A., et al.
Publicado: (2021)

Pharmacological cancer treatment and venous thromboembolism risk
por: Muñoz Martín, Andrés J, et al.
Publicado: (2020)

Application of the Khorana score for cancer-associated thrombosis prediction in patients of East Asian ethnicity undergoing ambulatory chemotherapy
por: Ha, Hyerim, et al.
Publicado: (2023)

S219: PREDICTING THROMBOTIC RISK IN PATIENTS WITH HODGKIN LYMPHOMA: A MULTICENTRIC STUDY OF THROLY AND KHORANA RISK SCORES
por: Assanto, Giovanni Manfredi, et al.
Publicado: (2023)

My remembrances of H.G. Khorana: exploring the mechanism of bacteriorhodopsin with site-directed mutagenesis and FTIR difference spectroscopy
por: Rothschild, Kenneth J.
Publicado: (2023)

Autism and ADHD Symptoms in Patients with OCD: Are They Associated with Specific OC Symptom Dimensions or OC Symptom Severity?
por: Anholt, Gideon E., et al.
Publicado: (2009)

Protein composition of coronavirus OC 43
por: Hierholzer, J.C., et al.
Publicado: (1972)

Nanomedicine Strategies for Heating “Cold” Ovarian Cancer (OC): Next Evolution in Immunotherapy of OC
por: Yang, Yuqi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_o1c9ehdjr0g4rt2memsl0n4ori